JP2011500650A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500650A5 JP2011500650A5 JP2010529411A JP2010529411A JP2011500650A5 JP 2011500650 A5 JP2011500650 A5 JP 2011500650A5 JP 2010529411 A JP2010529411 A JP 2010529411A JP 2010529411 A JP2010529411 A JP 2010529411A JP 2011500650 A5 JP2011500650 A5 JP 2011500650A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- aplidine
- cancer
- gemcitabine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98146307P | 2007-10-19 | 2007-10-19 | |
| PCT/EP2008/064117 WO2009050296A1 (en) | 2007-10-19 | 2008-10-20 | Improved antitumoral treatments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011500650A JP2011500650A (ja) | 2011-01-06 |
| JP2011500650A5 true JP2011500650A5 (enExample) | 2011-12-08 |
Family
ID=40097474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010529411A Pending JP2011500650A (ja) | 2007-10-19 | 2008-10-20 | 改良された抗腫瘍治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20100240595A1 (enExample) |
| EP (1) | EP2205263A1 (enExample) |
| JP (1) | JP2011500650A (enExample) |
| AU (1) | AU2008313627A1 (enExample) |
| CA (1) | CA2703024A1 (enExample) |
| WO (1) | WO2009050296A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1229922B1 (en) * | 1999-11-15 | 2007-06-06 | Pharma Mar, S.A. | Aplidine treatment of cancers |
| MX2008010999A (es) * | 2006-02-28 | 2008-09-08 | Pharma Mar Sa | Tratamientos anti-tumor mejorados. |
| CN101965191A (zh) * | 2008-03-07 | 2011-02-02 | 法马马有限公司 | 改善的抗癌治疗 |
| TWI807411B (zh) | 2017-04-27 | 2023-07-01 | 西班牙商瑪製藥股份有限公司 | 抗腫瘤化合物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4493796A (en) * | 1980-09-12 | 1985-01-15 | Board Of Trustees, Univ. Of Ill. | Didemnins A, B, C, and derivatives thereof, as antiviral agents |
| US4950649A (en) * | 1980-09-12 | 1990-08-21 | University Of Illinois | Didemnins and nordidemnins |
| IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
| ATE74761T1 (de) * | 1985-09-20 | 1992-05-15 | Cernitin Sa | Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung. |
| US20030148933A1 (en) * | 1990-10-01 | 2003-08-07 | Pharma Mar S.A. | Derivatives of dehydrodidemnin B |
| GB8922026D0 (en) * | 1989-09-29 | 1989-11-15 | Pharma Mar Sa | Novel anti-viral and cytotoxic agent |
| US5580871A (en) * | 1992-11-20 | 1996-12-03 | The Dupont Merck Pharmaceutical Company | 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and alpha1 -antagonist activity |
| US5462726A (en) * | 1993-12-17 | 1995-10-31 | Bristol-Myers Squibb Company | Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents |
| US6156724A (en) * | 1996-06-07 | 2000-12-05 | Rinehart; Kenneth L. | Uses of didemnins as immunomodulating agents |
| US6034058A (en) * | 1997-04-15 | 2000-03-07 | Rinehart; Kenneth L. | Semi-synthetic alanyl dilemnin analogs |
| AU740598B2 (en) * | 1997-05-07 | 2001-11-08 | William J. Crumb | Aplidine as an L-type calcium channel enhancer |
| US6245759B1 (en) * | 1999-03-11 | 2001-06-12 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| EP1229922B1 (en) * | 1999-11-15 | 2007-06-06 | Pharma Mar, S.A. | Aplidine treatment of cancers |
| US6509315B1 (en) * | 2000-04-07 | 2003-01-21 | The Trustees Of The University Of Pennsylvania | Didemnin analogs and fragments and methods of making and using them |
| DK1276491T3 (da) * | 2000-04-07 | 2007-02-05 | Univ Pennsylvania | Tamandarin- og didemnin-analoger og fremgangsmåder til fremstilling og anvendelse af dem |
| UA76718C2 (uk) * | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
| KR20030038812A (ko) * | 2000-10-12 | 2003-05-16 | 파르마 마르, 에스.에이. | 암 치료 방법 |
| DE60229414D1 (de) * | 2001-10-19 | 2008-11-27 | Pharma Mar Sa | Verwendung von aplidine in der behandlung von pankreaskrebs |
| NZ541611A (en) * | 2003-03-12 | 2008-04-30 | Dana Farber Cancer Inst Inc | Aplidine for multiple myeloma treatment |
| WO2004080421A2 (en) * | 2003-03-12 | 2004-09-23 | Pharma Mar, S.A. | Improved antitumoral treatments |
| WO2004084812A2 (en) * | 2003-03-21 | 2004-10-07 | Joullie Madeleine M | Tamandarin analogs and fragments thereof and methods of making and using |
| MX2008010999A (es) * | 2006-02-28 | 2008-09-08 | Pharma Mar Sa | Tratamientos anti-tumor mejorados. |
-
2008
- 2008-10-20 EP EP08840135A patent/EP2205263A1/en not_active Withdrawn
- 2008-10-20 AU AU2008313627A patent/AU2008313627A1/en not_active Abandoned
- 2008-10-20 US US12/682,910 patent/US20100240595A1/en not_active Abandoned
- 2008-10-20 JP JP2010529411A patent/JP2011500650A/ja active Pending
- 2008-10-20 CA CA2703024A patent/CA2703024A1/en not_active Abandoned
- 2008-10-20 WO PCT/EP2008/064117 patent/WO2009050296A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016528162A5 (enExample) | ||
| JP2015523397A5 (enExample) | ||
| EA200901155A1 (ru) | Модуляторы фармакокинетических свойств терапевтических препаратов (варианты) и их использование в терапии | |
| BRPI0906181A2 (pt) | "método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer" | |
| JP2006504723A5 (enExample) | ||
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| JP2010222367A5 (enExample) | ||
| JP2014532704A5 (enExample) | ||
| JP2011515481A5 (enExample) | ||
| HK1198869A1 (en) | Combination treatments for hepatitis c | |
| JP2012193216A5 (enExample) | ||
| JP2015524444A5 (enExample) | ||
| BR112012003283A8 (pt) | sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, composição farmacêutica, produto, kit, uso de um sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, e, método de introdução de uma molécula de medicamento no citosol de uma célula em um paciente. | |
| JP2012517478A5 (enExample) | ||
| JP2012517427A5 (enExample) | ||
| RU2015126661A (ru) | Пероральная комбинация для предотвращения и лечения патологий мочевого пузыря, органов малого таза и мочеполового аппарата | |
| JP2013518124A5 (enExample) | ||
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| JP2006500346A5 (enExample) | ||
| RU2008152341A (ru) | Применение аллопуринола для лечения ладонно-подошвенной эритродизестезии | |
| JP2013541583A5 (enExample) | ||
| JP2015537009A5 (enExample) | ||
| JP2009539994A5 (enExample) | ||
| ATE543492T1 (de) | Behandlung von lungenkrebs | |
| JP2013544892A5 (enExample) |